The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
Children and teenagers will be special populations considered in this protocol.
Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.
Subjects with NASH, NAFLD, Fibrosis, Cirrhosis, Hepatitis B or C, HIV or any form of Liver Disease.
Cohort
Cross-sectional
Not listed
Number of samples collected
Total number of samples collected
Click on the lead sponsor to view all of their trials.
